Search results for "Highlights"
Avoiding hypoglycemia most compelling reason for deintensifying diabetes meds
Researchers presented older adults with type 2 diabetes with three scenarios in which deintensification may be indicated—poor health, limited life expectancy, and high hypoglycemia risk—and found that 8%, 4%, and 75%, respectively, viewed deintensification positively.
https://diabetes.acponline.org/archives/2022/10/14/3.htm
14 Oct 2022
Newer oral diabetes meds could provide significant benefits in type 1 diabetes
A retrospective chart review found that glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors were associated with benefits including weight loss and reduced use of insulin in patients with type 1 diabetes.
https://diabetes.acponline.org/archives/2022/11/11/1.htm
11 Nov 2022
Initiation of glucose-lowering therapies may be associated with reduced physical activity
An analysis of 148 participants from three randomized trials found that starting liraglutide, empagliflozin, or sitagliptin was associated with reduction in physical activity of about 1,000 steps per day or 10 minutes of moderate to vigorous physical activity per day.
https://diabetes.acponline.org/archives/2022/09/16/2.htm
16 Sep 2022
Patients diagnosed by OGTT without elevated HbA1c had similar CV, renal disease risks as those without diabetes
A prospective U.K. study found that patients with diabetes based on an oral glucose tolerance test (OGTT) often did not have a diabetic HbA1c level, and risks of cardiovascular (CV) and kidney disease in these patients were similar to those in the nondiabetic general population.
https://diabetes.acponline.org/archives/2022/09/16/3.htm
16 Sep 2022
Comprehensive telehealth approach improved HbA1c in type 2 diabetes
Compared with a simpler approach of telemonitoring and care coordination, an intervention that added self-management and diet/activity support, medication management, and depression care improved outcomes in veterans with poorly controlled type 2 diabetes, a trial found.
https://diabetes.acponline.org/archives/2022/08/12/2.htm
12 Aug 2022
Review finds blood pressure-lowering effects weaker in patients with type 2 diabetes
Absolute risk reductions did not differ substantially between people with and without type 2 diabetes because of the higher absolute cardiovascular risk among those with the condition, according to a new meta-analysis.
https://diabetes.acponline.org/archives/2022/08/12/1.htm
12 Aug 2022
Glucose-lowering treatment after type 2 diabetes diagnosis differed by race/ethnicity
Among 77,199 patients in a U.S. health system with a new diagnosis of diabetes from 2005 to 2016, 47% started a diabetes medication within 12 months. Prevalence differed by race and ethnicity, although the difference was mitigated by variation in HbA1c levels.
https://diabetes.acponline.org/archives/2022/08/12/3.htm
12 Aug 2022
Spotlight on inpatient hyperglycemia
A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
https://diabetes.acponline.org/archives/2022/07/08/5.htm
8 Jul 2022
Dietary protein sources associated with type 2 diabetes risk, study finds
Data from the Women's Health Initiative indicated that when 5% of energy intake from plant protein was substituted for animal protein, type 2 diabetes risk was estimated to decrease by approximately 21%.
https://diabetes.acponline.org/archives/2022/07/08/3.htm
8 Jul 2022
Disparities by race, hospital type exist in diabetes-related lower-extremity amputations
The authors of a recent study called for public awareness, screening, and accessible and early multidisciplinary care, as well as neighborhood-level public health interventions, to reduce the disproportionate burden of lower-extremity amputation in underserved communities.
https://diabetes.acponline.org/archives/2022/07/08/2.htm
8 Jul 2022